$DSWL Balance Sheet | Understand Stock

$DSWL

$2.95 -$0.03 (1.01%) Close

$DSWL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Mar 31, 2022	Q4 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Mar 31, 2014	Q4 FY2013 As of Mar 31, 2013	Q4 FY2012 As of Mar 31, 2012
Current assets:
Cash and cash equivalents
Time deposits with original maturities over three months
Marketable securities (note 3)
Time deposits maturing over twelve months - current portion
Time deposit with original maturities over twelve months – current
Marketable securities
Available-for-sale securities (note 4)
Held-to-maturity investment
Accounts receivable, less allowances for credit losses of $24 and $22 at March 31, 2025 and 2026, respectively
Inventories, net
Prepaid expenses and other current assets
Assets held for sale (note 7)
Total current assets

Property, plant and equipment, net
Deferred income tax assets (note 10)
Time deposits maturing over twelve months
Goodwill (note 2)
Deferred tax assets
Time deposits with original maturities over twelve months
Total assets
Current liabilities:
Accounts payable
Other accrued liabilities (note 7)
Accrued payroll and employee benefits
Customer deposits
Other accrued liabilities
Income taxes payable
Total current liabilities
Deferred income tax liabilities
Total liabilities
Deferred income tax liabilities (note 8)
Dividend payable

Shareholders’ equity:
Common shares nil par value; authorized 30,000,000 shares as of March 31, 2022 and 2023; 17,081,810 and 17,081,810 shares issued as of March 31, 2022 and 2023; 15,935,239 and 15,935,239 shares outstanding as of March 31, 2022 and 2023
Common shares nil par value; authorized 30,000,000 shares as of March 31, 2025 and 2026; 17,081,810 shares issued as of March 31, 2025 and 2026; 15,935,239 shares outstanding as of March 31, 2025 and 15,885,239 shares outstanding as of March 31,2026
Treasury stock at cost; 1,146,571 shares as of March 31, 2025 and 1,196,571 shares as of March 31, 2026
Additional paid-in capital
Accumulated other comprehensive income
Retained earnings
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments